These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 9569075

  • 1. An initially double-blind controlled 96 week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica.
    Dasgupta B, Dolan AL, Panayi GS, Fernandes L.
    Br J Rheumatol; 1998 Feb; 37(2):189-95. PubMed ID: 9569075
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica.
    Dolan AL, Moniz C, Dasgupta B, Li F, Mackintosh C, Todd P, Corrigall V, Panayi GS.
    Arthritis Rheum; 1997 Nov; 40(11):2022-9. PubMed ID: 9365092
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
    Devauchelle-Pensec V, Carvajal-Alegria G, Dernis E, Richez C, Truchetet ME, Wendling D, Toussirot E, Perdriger A, Gottenberg JE, Felten R, Fautrel BJ, Chiche L, Hilliquin P, Le Henaff C, Dervieux B, Direz G, Chary-Valckenaere I, Cornec D, Guellec D, Marhadour T, Nowak E, Saraux A.
    JAMA; 2022 Sep 20; 328(11):1053-1062. PubMed ID: 36125471
    [Abstract] [Full Text] [Related]

  • 7. PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial.
    Marsman DE, Bolhuis TE, den Broeder N, den Broeder AA, van der Maas A.
    Trials; 2022 Apr 15; 23(1):318. PubMed ID: 35428320
    [Abstract] [Full Text] [Related]

  • 8. A longterm prospective study of the equipotency between deflazacort and prednisolone in the treatment of patients with polymyalgia rheumatica.
    Krogsgaard MR, Lund B, Johnsson B.
    J Rheumatol; 1995 Sep 15; 22(9):1660-2. PubMed ID: 8523341
    [Abstract] [Full Text] [Related]

  • 9. Polymyalgia rheumatica: inflammation suppression with low dose of methylprednisolone or modified-release prednisone.
    Benucci M, Olivito B, Manfredi M, Meacci F, Infantino M, Li Gobbi F, Sarzi-Puttini P, Marcassa C, Atzeni F.
    Eur Rev Med Pharmacol Sci; 2015 Sep 15; 19(5):745-51. PubMed ID: 25807425
    [Abstract] [Full Text] [Related]

  • 10. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial.
    Caporali R, Cimmino MA, Ferraccioli G, Gerli R, Klersy C, Salvarani C, Montecucco C, Systemic Vasculitis Study Group of the Italian Society for Rheumatology.
    Ann Intern Med; 2004 Oct 05; 141(7):493-500. PubMed ID: 15466766
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica.
    Hutchings A, Hollywood J, Lamping DL, Pease CT, Chakravarty K, Silverman B, Choy EH, Scott DG, Hazleman BL, Bourke B, Gendi N, Dasgupta B.
    Arthritis Rheum; 2007 Jun 15; 57(5):803-9. PubMed ID: 17530680
    [Abstract] [Full Text] [Related]

  • 12. Changes in bone mass during low dose corticosteroid treatment in patients with polymyalgia rheumatica: a double blind, prospective comparison between prednisolone and deflazacort.
    Krogsgaard MR, Thamsborg G, Lund B.
    Ann Rheum Dis; 1996 Feb 15; 55(2):143-6. PubMed ID: 8712867
    [Abstract] [Full Text] [Related]

  • 13. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
    van der Veen MJ, Dinant HJ, van Booma-Frankfort C, van Albada-Kuipers GA, Bijlsma JW.
    Ann Rheum Dis; 1996 Apr 15; 55(4):218-23. PubMed ID: 8733437
    [Abstract] [Full Text] [Related]

  • 14. Circadian variations in clinical symptoms and concentrations of inflammatory cytokines, melatonin, and cortisol in polymyalgia rheumatica before and during prednisolone treatment: a controlled, observational, clinical experimental study.
    Galbo H, Kall L.
    Arthritis Res Ther; 2016 Jul 26; 18(1):174. PubMed ID: 27455959
    [Abstract] [Full Text] [Related]

  • 15. Patient-reported outcomes in polymyalgia rheumatica.
    Matteson EL, Maradit-Kremers H, Cimmino MA, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Slott Jensen H, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Cantini F, Nannini C, Macchioni P, Pipitone N, Del Amo M, Espígol-Frigolé G, Cid MC, Martínez-Taboada VM, Nordborg E, Direskeneli H, Aydin SZ, Ahmed K, Hazelman B, Pease C, Wakefield RJ, Luqmani R, Abril A, Marcus R, Gonter NJ, Maz M, Crowson CS, Dasgupta B.
    J Rheumatol; 2012 Apr 26; 39(4):795-803. PubMed ID: 22422492
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr 26; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 18. Methylprednisolone acetate versus oral prednisolone in moderately active ulcerative colitis.
    Sood A, Midha V, Sood N, Kaushal V, Awasthi G.
    Indian J Gastroenterol; 2002 Apr 26; 21(1):11-3. PubMed ID: 11871829
    [Abstract] [Full Text] [Related]

  • 19. Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica.
    Dejaco C, Singh YP, Perel P, Hutchings A, Camellino D, Mackie S, Matteson EL, Dasgupta B.
    Ann Rheum Dis; 2015 Oct 26; 74(10):1808-17. PubMed ID: 26359489
    [Abstract] [Full Text] [Related]

  • 20. Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.
    Salvarani C, Boiardi L, Macchioni P, Rossi F, Tartoni P, Casadei Maldini M, Mancini R, Beltrandi E, Portioli I.
    Ann Rheum Dis; 1995 Aug 26; 54(8):640-4. PubMed ID: 7677440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.